相关实验视频
Updated: Jul 31, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
12.4K
中国肌肉侵入性膀癌队列的综合遗传概况
Sujun Han1, Yining Li2, Dong Chen1
1Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Clinical genitourinary cancer
|January 16, 2025
概括
这项研究标志着中国肌肉侵入性膀癌 (MIBC) 的突变,发现TP53和TTN的频繁变化. 它确定了潜在的治疗点,并将DNA损伤修复 (DDR) 突变与高瘤突变负担 (TMB) 联系起来.
科学领域:
- 基因组学就是基因组学.
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 肌肉侵入性膀癌 (MIBC) 是一个重大的健康问题.
- 了解MIBC的基因组景观对于开发向疗法至关重要.
- 关于中国人群中MIBC的特定突变谱的数据有限.
研究的目的:
- 描述MIBC的中国患者突变的谱.
- 为了识别经常发生突变的基因和DNA损伤修复 (DDR) 基因.
- 探索潜在的治疗点和与瘤突变负担 (TMB) 和微卫星不稳定性 (MSI) 的关联.
主要方法:
- 来自62名中国MIBC患者的瘤组织或血液样本的整体外基因组测序.
- 在已识别的基因中分析突变频率.
- 与来自癌症基因组图谱 (TCGA) 数据库的323个白色MIBC样本的数据进行比较.
- 统计分析以评估突变,TMB,MSI,吸烟和饮酒之间的关联.
主要成果:
- 最常发生突变的基因是TP53 (41%) 和TTN (41%).
- 关键突变的DNA损伤修复 (DDR) 基因包括TP53 (49%) 和SMARCA4 (10%).
- 证实了DDR突变与高TMB之间的关联 (P = .022).
- 在吸烟者和非吸烟者 (P = .022),饮酒者和非饮酒者 (P = .018) 之间观察到微观卫星不稳定性 (MSI) 的显著差异.
- 与TCGA队列共同突变的驱动基因包括TP53,KMT2D,KMT2C和FGFR3.3.
- 与TCGA白人队列相比,对FRG1,CDC27和IGSF3等基因观察到明显的突变频率.
结论:
- 这项研究为中国MIBC的基因组变化提供了全面的见解.
- 这些发现突出了这一群体内特定的突变模式和潜在的治疗点.
- 结果可能为未来的临床应用和个性化治疗策略提供有价值的线索.
相关概念视频
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...